Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 4:04 PM View:  | Bausch & Lomb Corp (BLCO) | 29-Mar-24 | Grant | 1,553 | $17.30 | $26,866.90 | 5% 31.4K to 32.95K | 4% |
| 03-Jan-24 4:41 PM View: | Bausch & Lomb Corp (BLCO) | 29-Dec-23 | Grant | 1,575 | $17.06 | $26,869.50 | 5% 29.82K to 31.4K | 6% |
| 03-Oct-23 10:00 PM View: | Bausch & Lomb Corp (BLCO) | 29-Sep-23 | Grant | 1,585 | $16.95 | $26,865.80 | 6% 28.24K to 29.82K | 6% |
| 05-Jul-23 4:05 PM View: | Bausch & Lomb Corp (BLCO) | 30-Jun-23 | Grant | 1,339 | $20.07 | $26,873.70 | 5% 26.9K to 28.24K | (10%) |
| 05-May-23 4:19 PM View: | Bausch & Lomb Corp (BLCO) | 04-May-23 | Grant | 12,857 | -- | -- | 92% 14.04K to 26.9K | |
| 04-Apr-23 6:02 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Mar-23 | Grant | 3,642 | $8.10 | $29,500.20 | < 1% 383.56K to 387.21K | |
| 04-Apr-23 4:16 PM View: | Bausch & Lomb Corp (BLCO) | 31-Mar-23 | Grant | 1,543 | $17.41 | $26,863.60 | 12% 12.5K to 14.04K | 3% |
| 03-Jan-23 5:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Dec-22 | Grant | 5,186 | $6.28 | $32,568.10 | 1% 378.38K to 383.56K | |
| 03-Oct-22 4:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Sep-22 | Grant | 4,989 | $6.89 | $34,374.20 | 1% 373.39K to 378.38K | |
| 05-Jul-22 5:59 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Jun-22 | Grant | 4,111 | $8.36 | $34,368.00 | 1% 369.28K to 373.39K | |
| 28-Jun-22 4:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Jun-22 | Grant | 34,387 | -- | -- | 10% 334.89K to 369.28K | |
| 12-May-22 7:37 PM View: | Bausch & Lomb Corp (BLCO) | 10-May-22 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 04-Apr-22 5:57 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Mar-22 | Grant | 1,504 | $22.85 | $34,366.40 | < 1% 333.39K to 334.89K | (5%) |
| 03-Jan-22 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Dec-21 | Grant | 1,245 | $27.61 | $34,374.40 | < 1% 332.14K to 333.39K | |
| 04-Oct-21 4:41 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Sep-21 | Grant | 1,234 | $27.85 | $34,366.90 | < 1% 330.91K to 332.14K | |
| 06-Aug-21 4:24 PM View: | Valeant Pharmaceuticals Int... (BHC) | 04-Aug-21 | Purchase | 10,000 | $25.01 | $250,123.00 | 3% 320.91K to 330.91K | |
| 03-May-21 4:00 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Apr-21 | Grant | 7,645 | -- | -- | 2% 312.09K to 319.74K | |
| 02-Apr-21 5:06 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Mar-21 | Grant | 1,070 | $31.74 | $33,961.80 | < 1% 311.02K to 312.09K | |
| 04-Jan-21 6:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Dec-20 | Grant | 1,622 | $20.80 | $33,737.60 | < 1% 309.4K to 311.02K | 5% |
| 02-Oct-20 5:01 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Sep-20 | Grant | 2,171 | $15.54 | $33,737.30 | < 1% 307.23K to 309.4K | |
| 02-Jul-20 4:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Jun-20 | Grant | 1,750 | $18.29 | $32,007.50 | < 1% 305.48K to 307.23K | |
| 01-May-20 4:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-May-20 | Grant | 11,037 | -- | -- | 4% 294.44K to 305.48K | |
| 01-May-20 4:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Apr-20 | Payment of Exercise | 624 | $18.11 | $11,300.60 | (< 1%) 295.07K to 294.44K | |
| 02-Apr-20 4:24 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Mar-20 | Grant | 2,016 | $15.50 | $31,248.00 | < 1% 293.05K to 295.07K | |
| 11-Mar-20 8:47 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Mar-20 | Private Purchase | 3,800 | $18.26 | $69,377.40 | 1% 289.25K to 293.05K | |
| 11-Mar-20 8:47 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-20 | Market Purchase | 5,000 | $23.08 | $115,415.00 | 2% 284.25K to 289.25K | (5%) |
| 02-Jan-20 4:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Dec-19 | Grant | 1,044 | $29.92 | $31,236.50 | < 1% 283.21K to 284.25K | |
| 02-Oct-19 5:33 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Sep-19 | Grant | 1,430 | $21.85 | $31,245.50 | < 1% 281.78K to 283.21K | (< 1%) |
| 02-Jul-19 4:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Jun-19 | Grant | 1,239 | $25.22 | $31,247.60 | < 1% 280.54K to 281.78K | |
| 03-May-19 4:13 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-May-19 | Grant | 10,633 | $23.51 | $249,982.00 | 4% 269.9K to 280.54K | 0% |
| 03-May-19 4:13 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-May-19 | Payment of Exercise | 3,996 | $23.63 | $94,425.50 | (1%) 273.9K to 269.9K | < 1% |
| 03-Apr-19 4:47 PM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Mar-19 | Grant | 1,265 | $24.70 | $31,245.50 | < 1% 272.63K to 273.9K | < 1% |
| 03-Jan-19 4:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 31-Dec-18 | Grant | 1,691 | $18.47 | $31,232.80 | < 1% 270.94K to 272.63K | 28% |
| 02-Oct-18 4:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Sep-18 | Grant | 1,217 | $25.67 | $31,240.40 | < 1% 269.73K to 270.94K | (8%) |
| 17-Sep-18 3:00 PM View: | Valeant Pharmaceuticals Int... (BHC) | 13-Sep-18 | Market Purchase | 125,000 | $23.96 | $2,995,000.00 | 86% 144.73K to 269.73K | (1%) |
| 03-Jul-18 4:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Jun-18 | Grant | 1,344 | $23.24 | $31,234.60 | < 1% 143.38K to 144.73K | 2% |
| 17-May-18 4:43 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-May-18 | Market Purchase | 15,000 | $21.83 | $327,450.00 | 13% 118.38K to 133.38K | 9% |
| 03-Jul-18 4:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-May-18 | Market Purchase | 10,000 | $21.80 | $218,000.00 | 7% 133.38K to 143.38K | 9% |
| 04-May-18 5:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-May-18 | Grant | 14,285 | -- | -- | 14% 104.5K to 118.79K | |
| 03-May-18 4:42 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-May-18 | Payment of Exercise | 3,522 | $18.07 | $63,642.50 | (3%) 108.02K to 104.5K | (31%) |
| 03-Apr-18 4:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Mar-18 | Grant | 1,962 | $15.92 | $31,235.00 | 2% 106.06K to 108.02K | 49% |
| 12-Mar-18 8:59 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-18 | Market Purchase | 10,000 | $15.34 | $153,400.00 | 10% 96.06K to 106.06K | 54% |
| 03-Jan-18 10:21 AM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Dec-17 | Grant | 1,503 | $20.78 | $31,232.30 | 2% 94.56K to 96.06K | 14% |
| 21-Nov-17 6:26 PM View: | Valeant Pharmaceuticals Int... (BHC) | 17-Nov-17 | Market Purchase | 10,000 | $14.33 | $143,300.00 | 12% 84.56K to 94.56K | 65% |
| 03-Oct-17 5:41 PM View: | Valeant Pharmaceuticals Int... (BHC) | 29-Sep-17 | Grant | 2,180 | $14.33 | $31,239.40 | 3% 82.38K to 84.56K | 65% |
| 22-Aug-17 4:39 PM View: | Valeant Pharmaceuticals Int... (BHC) | 21-Aug-17 | Market Purchase | 10,000 | $14.33 | $143,296.00 | 14% 72.38K to 82.38K | 65% |
| 05-Jul-17 4:36 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Jun-17 | Grant | 1,807 | $17.30 | $31,261.10 | 3% 70.57K to 72.38K | 37% |
| 15-May-17 5:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-May-17 | Market Purchase | 20,000 | $13.90 | $278,000.00 | 40% 50.57K to 70.57K | 71% |
| 08-May-17 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-May-17 | Payment of Exercise | 2,148 | $9.66 | $20,749.70 | (4%) 52.72K to 50.57K | (145%) |
| 08-May-17 4:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-May-17 | Grant | 25,406 | -- | -- | 93% 27.31K to 52.72K |